GEHC GE HealthCare Technologies Inc.

Overview and Growth

Fiscal 2025 results for GE HealthCare Technologies Inc. combined $20.62B of revenue with net income of $2.08B and an operating cash inflow of $1.99B. The $20.62B revenue base provides substantial context for the company’s earnings, cash generation, and capital requirements. The top line expanded 4.8% from $19.67B in fiscal 2024, increasing the company’s operating scale. The company reported diluted EPS of $4.55, adding a shareholder-level measure to the absolute income figures considered below. The per-share result recorded a 4.8% increase from fiscal 2024 diluted EPS of $4.34. Revenue equaled 0.56x of total assets, indicating how much reported top-line activity the company produced relative to its period-end asset base.

Profitability

The first profit layer was $8.25B of gross profit, the amount available after reported direct revenue costs to absorb operating expenses. Gross margin was 40.0%, so that share of each revenue unit remained after the cost of revenue reported for the period. The reported operating result was $2.76B, capturing profitability after direct costs and the operating expenses reflected in the statements. Operating margin measured 13.4%, showing the portion of revenue preserved after the full set of operating costs. After all reported below-operating-line items, the company recorded net income of $2.08B for the fiscal year. Net margin was 10.1%, meaning that this portion of revenue remained as net income after all recognized expenses. Before income taxes, the company reported $2.77B of earnings, providing a bridge between the operating result and final net income. The pretax margin was 13.4%, relating income before taxes directly to revenue. The reported income-tax provision was $614.00M, the amount recognized between pretax income and the final net-income result. The effective relationship between income tax and positive pretax income was 22.2%, without assuming a statutory-rate comparison.

Liquidity and Capital Structure

Total assets were $36.91B, supported by $26.31B of liabilities and $10.39B of shareholder equity. Current assets were $12.50B against $9.11B of current liabilities, framing the resources and obligations classified within the near-term balance-sheet horizon. Current assets covered current liabilities by 1.37x, leaving a positive buffer for near-term obligations. Cash and equivalents totaled $4.49B, identifying the most liquid reported component available within the broader current-asset balance. Measured only with cash and equivalents, coverage of current liabilities was 49.3%, excluding receivables and other current assets. Total debt was $10.00B, establishing the amount of borrowing carried within the company’s capital structure. Against book equity, debt measured 0.96x, placing the company’s financial leverage in clear balance-sheet terms. Debt represented 27.1% of total assets, placing borrowing in the context of the company’s full resource base. Relative to total assets, liabilities measured 71.3%, complementing the separate equity-based view of the company’s capital structure. Cash and equivalents equaled 12.2% of total assets, showing the liquid cash component within the company’s broader resource base.

Cash Flow and Earnings Quality

Cash flow from operations was $1.99B, a reported cash inflow that can be compared directly with net income and capital spending. Against net income, operating cash flow measured 0.95x, showing the relationship between accrual earnings and operating cash. The cash-flow statement records $482.00M of capital expenditures, the investment amount considered after operating cash generation. Capital spending absorbed 24.3% of operating cash flow, quantifying the share of cash from operations directed to investment. The combination of operating cash flow and capital spending produced $1.50B of positive free cash flow for the period. Free cash flow represented 7.3% of revenue, linking post-investment cash generation with the company’s operating scale. The free-cash-flow-to-assets relationship was 4.1%, comparing post-investment cash with the balance-sheet asset base.

Based on the annual report for the fiscal year ending Dec 31, 2025. Analysis generated Sep 24, 2026.